Transcriptional Regulation of Angiotensinogen Gene
Transcriptional Regulation of Angiotensinogen Gene
批准号:
8476249
负责人:
ASHOK KUMAR
金额:
$35.3万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-01 至 2015-06-30
关键词:
AcuteAcute-Phase ProteinsAdultAffectAfrican AmericanAgingAllelesAmericanAngiotensin IIAngiotensinogenBindingBlood PressureCCAAT-Enhancer-Binding ProteinsCaucasiansCaucasoid RaceDevelopmentDexamethasoneEssential HypertensionFamilyFrequenciesGene ExpressionGene FrequencyGenesGenetic PolymorphismGenetic TranscriptionGenetic TranslationGlucocorticoidsHaplotypesHealthHeart failureHepatocyteHumanHypertensionIncidenceInflammationInterleukin-6Japanese PopulationKidney FailureKnock-in MouseLeftLiverMessenger RNAMolecularMyocardial InfarctionNucleosidesPatientsPhasePlasmaPlayPopulationPrevalencePromoter RegionsProteinsRecombinantsReninRenin-Angiotensin SystemReporterRisk FactorsRoleSiteStrokeTissuesTranscriptional RegulationTransfectionTransgenic MiceVariantVascular Diseasesblood pressure regulationin vivomalepromotertranscription factorvasoconstriction
中文摘要
描述(由申请人提供):高血压是心肌梗死、心力衰竭、血管疾病、中风和肾功能衰竭的严重危险因素。肾素-血管紧张素系统在血压调节中起着重要作用。先前的研究表明:(a)血管紧张素原(AGT)基因位点与人类原发性高血压有关,(b) AGT基因的变异-6A与高加索和日本受试者的高血压有关,(c)转基因小鼠中AGT基因的过表达会增加血压。我们在人类AGT基因启动子-217位点发现了A/G多态性,并且在非裔美国高血压患者中-217位点等位基因A的频率显著增加。AGT基因主要在肝脏中表达,我们已经证明含有核苷A在-217位点的AGT基因启动子的报告构建物在人肝细胞瞬时转染时增加了基础启动子和IL-6诱导的启动子活性。虽然hAGT基因在其启动子1.2Kb区域有7个多态性位点,但变异-217A几乎总是与-532T、-793A和-1074T一起出现,而变异-217G、-532C、-793G和-1074G总是一起出现,形成两个单倍型。由于等位基因-6A是非洲裔美国人的主要等位基因(频率为0.85),因此AGT基因可细分为四种单倍型-6A:- 217a (AA);6: -217克(AG);-6G:-217A (GA)和-6G:-217G (GG)。单倍型GA和GG非常罕见,AA和AG是两个主要的单倍型。我们已经证明:(a)与AG单倍型相比,高血压患者AA单倍型的频率增加;(b)与AG单倍型相比,含有AA单倍型的报告基因结构增加了基础启动子和IL-6诱导的启动子活性。由于炎症在高血压中起重要作用,我们的假设是AGT基因AA单倍型转录增加在高血压的发生发展中起重要作用。为了证明这一假设,我们在HPRT位点采用敲入策略,产生了含有人肾素基因和hAGT基因AA或AG单倍型的转基因小鼠。我们已经证明,与AG单倍型相比,含有AGT基因AA单倍型的双转基因小鼠的AGT mRNA和蛋白水平增加。我们还发现,与含有hAGT基因和hRen基因AG单倍型的转基因小鼠相比,含有hAGT基因和hRen基因AA单倍型的双转基因小鼠血压升高。我们现在将在体内研究这些单倍型对血压调节的作用,在含有hAGT基因和hRen基因的AA或AG单倍型但缺乏mAGT基因的转基因小鼠中。
英文摘要
DESCRIPTION (provided by applicant): Hypertension is a serious risk factor for myocardial infarction, heart failure, vascular disease, stroke, and renal failure. The renin-angiotensin system plays an important role in the regulation of blood pressure. Previous studies have suggested that: (a) angiotensinogen (AGT) gene locus is associated with human essential hypertension, (b) variant -6A of the AGT gene is associated with hypertension in Caucasian and Japanese subjects and (c) over-expression of the AGT gene increases blood pressure in transgenic mice. We have found an A/G polymorphism at -217 in the human AGT gene promoter and have shown that frequency of allele A at -217 is significantly increased in African-American hypertensive patients. AGT gene is primarily expressed in the liver and we have shown that reporter constructs containing AGT gene promoter with nucleoside A at -217 have increased basal and IL-6 induced promoter activity on transient transfection in human liver cells. Although hAGT gene has seven polymorphic sites in 1.2Kb region of its promoter, variants -217A almost always occurs with -532T, -793A, and -1074T and variants -217G, -532C, -793G, and -1074G always occur together forming two haplotypes. Since allele - 6A is the predominant allele (frequency 0.85) in African-Americans, AGT gene can be subdivided into four haplotypes -6A:-217A (AA); -6A:-217G (AG); -6G:-217A (GA) and -6G:-217G (GG). However, haplotypes GA and GG are very rare leaving AA and AG as two prominent haplotypes. We have shown that: (a) frequency of AA haplotype is increased in hypertensive patients as compared to the AG haplotype and (b) reporter constructs containing AA haplotype have increased basal as well as IL-6 induced promoter activity as compared to AG haplotype. Since inflammation plays an important role in hypertension, our hypothesis is that increased transcription of AA haplotype of the AGT gene plays an important role in the development of hypertension. In order to prove this hypothesis, we have generated transgenic mice containing human renin gene and either AA or AG haplotype of the hAGT gene using knock-in strategy at the HPRT locus. We have shown that AGT mRNA and protein level is increased in double transgenic mice containing AA haplotype of the AGT gene as compared to the AG haplotype. We have also shown that double transgenic mice containing AA haplotype of the hAGT gene and hRen gene have increased blood pressure as compared to transgenic mice containing AG haplotype of the hAGT gene and hRen gene. We will now study the role of these haplotypes on blood pressure regulation in an in vivo situation in transgenic mice containing either AA or AG haplotype of the hAGT gene and hRen gene but devoid of mAGT gene.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TWEAK/Fn14/UPR Signaling in Skeletal Muscle Wasting
-
批准号:10660397
-
项目类别:
-
资助金额:$55.16万
-
财政年份:2023
-
负责人:ASHOK KUMAR
-
依托单位:
TAK1 signaling in skeletal muscle
-
批准号:10201515
-
项目类别:
-
资助金额:$42.97万
-
财政年份:2019
-
负责人:ASHOK KUMAR
-
依托单位:
TAK1 signaling in skeletal muscle
-
批准号:10005646
-
项目类别:
-
资助金额:$44.3万
-
财政年份:2019
-
负责人:ASHOK KUMAR
-
依托单位:
Non-Coding Variants of Angiotensinogen Gene and Hypertension
-
批准号:9197334
-
项目类别:
-
资助金额:$61.5万
-
财政年份:2016
-
负责人:ASHOK KUMAR
-
依托单位:
Non-Coding Variants of Angiotensinogen Gene and Hypertension
-
批准号:9325162
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2016
-
负责人:ASHOK KUMAR
-
依托单位:
MYD88 Signaling in Mammalian Myoblast Fusion
-
批准号:9336240
-
项目类别:
-
资助金额:$33.74万
-
财政年份:2015
-
负责人:ASHOK KUMAR
-
依托单位:
MYD88 Signaling in Mammalian Myoblast Fusion
-
批准号:9144184
-
项目类别:
-
资助金额:$33.74万
-
财政年份:2015
-
负责人:ASHOK KUMAR
-
依托单位:
Aldosterone Synthase & Hypertension
-
批准号:9052214
-
项目类别:
-
资助金额:$22.24万
-
财政年份:2014
-
负责人:ASHOK KUMAR
-
依托单位:
Aldosterone Synthase and Hypertension
-
批准号:8673375
-
项目类别:
-
资助金额:$63.24万
-
财政年份:2014
-
负责人:ASHOK KUMAR
-
依托单位:
Aldosterone Synthase & Hypertension
-
批准号:8837685
-
项目类别:
-
资助金额:$62.29万
-
财政年份:2014
-
负责人:ASHOK KUMAR
-
依托单位:
TAK1/TRAF6 Signaling in Skeletal Muscle
-
批准号:8502172
-
项目类别:
-
资助金额:$31.99万
-
财政年份:2011
-
负责人:ASHOK KUMAR
-
依托单位:
Genetics of Hypertension
-
批准号:8302314
-
项目类别:
-
资助金额:$37.45万
-
财政年份:2011
-
负责人:ASHOK KUMAR
-
依托单位:
TAK1/TRAF6 Signaling in Skeletal Muscle
-
批准号:8286234
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2011
-
负责人:ASHOK KUMAR
-
依托单位:
Genetics of Hypertension
-
批准号:8392241
-
项目类别:
-
资助金额:$35.65万
-
财政年份:2011
-
负责人:ASHOK KUMAR
-
依托单位:
TAK1/TRAF6 Signaling in Skeletal Muscle
-
批准号:8690762
-
项目类别:
-
资助金额:$33.0万
-
财政年份:2011
-
负责人:ASHOK KUMAR
-
依托单位:
Genetics of Hypertension
-
批准号:8188803
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2011
-
负责人:ASHOK KUMAR
-
依托单位:
TAK1/TRAF6 Signaling in Skeletal Muscle
-
批准号:8106684
-
项目类别:
-
资助金额:$35.8万
-
财政年份:2011
-
负责人:ASHOK KUMAR
-
依托单位:
Genetics of Hypertension
-
批准号:8585083
-
项目类别:
-
资助金额:$36.7万
-
财政年份:2011
-
负责人:ASHOK KUMAR
-
依托单位:
Transcriptional Regulation of Angiotensinogen Gene
-
批准号:8413074
-
项目类别:
-
资助金额:$23.56万
-
财政年份:2009
-
负责人:ASHOK KUMAR
-
依托单位:
Transcriptional Regulation of Angiotensinogen Gene
-
批准号:7905982
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2009
-
负责人:ASHOK KUMAR
-
依托单位:
海外基金